Analyst Ratings for Fresenius Medical Care (FMS)
FMS Rating Summary
FMS Price Target Summary
- Highest: $74.00 (Piper Jaffray)
- Lowest: $36.00 (RBC Capital)
- Average: $55.00
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$55.00 (+64.7%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/7/2013 | RBC Capital | Downgrade | Sector Perform (Outperform) |
36.00 (N/A) |
34.07 | 33.40 | -1.97% | Details |
| 1/14/2013 | Berenberg | Upgrade | Buy (Hold) |
N/A (N/A) |
32.26 | 33.40 | 3.53% | Details |
| 1/10/2013 | Credit Suisse | Downgrade | Neutral (Outperform) |
N/A (N/A) |
32.76 | 33.40 | 1.95% | Details |
| 11/12/2012 | Goldman Sachs | Upgrade | Conviction Buy (Buy) |
N/A (N/A) |
66.66 | 33.40 | -49.89% | Details |
| 11/1/2012 | Piper Jaffray | Downgrade | Neutral (Overweight) |
74.00 (78.00) |
70.38 | 33.40 | -52.54% | Details |
| 11/1/2012 | BofA/Merrill Lynch | Downgrade | Neutral (Buy) |
N/A (N/A) |
70.38 | 33.40 | -52.54% | Details |
| 9/18/2012 | JPMorgan | Downgrade | Neutral (Overweight) |
N/A (N/A) |
72.80 | 33.40 | -54.12% | Details |
| 8/31/2012 | Societe Generale | New Coverage | Buy (N/A) |
N/A (N/A) |
71.25 | 33.40 | -53.12% | Details |
| 8/2/2012 | HSBC | Downgrade | Neutral (Overweight) |
N/A (N/A) |
71.80 | 33.40 | -53.48% | Details |
| 7/20/2012 | Jefferies | Downgrade | Hold (Buy) |
N/A (N/A) |
71.82 | 33.40 | -53.49% | Details |
| 2/16/2012 | Citi | Downgrade | Neutral (N/A) |
N/A (N/A) |
74.13 | 33.40 | -54.94% | Details |
| 2/15/2012 | WestLB | Downgrade | Neutral (N/A) |
N/A (N/A) |
72.91 | 33.40 | -54.19% | Details |
| 12/5/2011 | Nomura Securities | Downgrade | Reduce (N/A) |
N/A (N/A) |
68.29 | 33.40 | -51.09% | Details |
| 12/1/2011 | Morgan Stanley | Upgrade | Overweight (N/A) |
N/A (N/A) |
69.01 | 33.40 | -51.6% | Details |
| 5/3/2011 | Macquarie | Downgrade | Neutral (N/A) |
N/A (N/A) |
77.95 | 33.40 | -57.15% | Details |
